Cancerous inhibitor of protein phosphatase 2A (CIP2A) is an independent prognostic marker in wild-type KRAS metastatic colorectal cancer after colorectal liver metastasectomy

BACKGROUND: The impact of KRAS signaling on cancerous inhibitor of protein phosphatase 2A (CIP2A) expression has not yet been explored. We investigated the impact of KRAS on CIP2A expression in colorectal cancer patients after colorectal liver metastasectomy. METHODS: We examined CIP2A expression by...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Kuen-Feng, Yen, Chueh-Chuan, Lin, Jen-Kou, Chen, Wei-Shone, Yang, Shung-Haur, Jiang, Jeng-Kai, Lan, Yuan-Tzu, Lin, Chun-Chi, Yu, Hui-Chuan, Hsu, Hui-Mei, Lin, Wen-Ling, Teng, Hao-Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4404594/
https://www.ncbi.nlm.nih.gov/pubmed/25896895
http://dx.doi.org/10.1186/s12885-015-1300-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4404594/
https://www.ncbi.nlm.nih.gov/pubmed/25896895
http://dx.doi.org/10.1186/s12885-015-1300-3

Ejemplares similares